drug
as of 2026-07-01Acamprosate
MeSH D000077443
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hannover Medical School
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
3
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
NCT00463346Phase 3Completed
Biomarker Study of Acamprosate in Schizophrenia
NCT00688324Phase 4Completed
KOLs & investigators
3
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
KOL
Helge Frieling, Prof., MD
personKOL score 5
Bernard A Fischer, M.D.
personKOL score 5
Ismene L Petrakis, MD
personKOL score —